PepeLaguarda/E+ via Getty Images Investment Overview Yesterday (May 4th), Crispr Therapeutics AG ( CRSP ), the Swiss-based, commercial stage CRISPR gene editing pioneer, announced its Q1 2026 earnings. The company reported $1m of collaboration revenue, and $458k of grant revenue. R&D costs were reported as $69m, G&A costs $17.2m, and collaboration expense $46m. Total operating expenses came to $13...
PepeLaguarda/E+ via Getty Images Investment Overview Yesterday (May 4th), Crispr Therapeutics AG ( CRSP ), the Swiss-based, commercial stage CRISPR gene editing pioneer, announced its Q1 2026 earnings. The company reported $1m of collaboration revenue, and $458k of grant revenue. R&D costs were reported as $69m, G&A costs $17.2m, and collaboration expense $46m. Total operating expenses came to $132m, and net loss $(122m), down from $(135m) in Q1 2026. Crispr Therapeutics also reported cash and equivalents of $423m, and marketable securities of $2bn, with no meaningful debt. Shares fell slightly in trading yesterday, dropping ~2% to a value of $52.3, reflecting a market cap valuation of $5.1bn. The stock has barely budged in value year-to-date, is up ~38% on a 12-month basis (at the time of writing), but down 55% on a five-year basis. Since its 2016 IPO, shares have risen in value by >270%. Let's start our analysis by discussing performance of CRISPR's only commercial-stage asset, the sickle cell disease ("SCD") / beta thalassemia ex vivo cell therapy Casgevy. Casgevy Revenues Fall Sequentially - Here's Why I Don't Think Shareholders Should Be Concerned Crispr Therapeutics secured FDA approval for its landmark ex-vivo sickle cell disease therapy Casgevy (exagamglogene autotemcel, or "exa-cel," for short) In December 2023 , and secured approval for Casgevy to treat transfusion dependent beta thalassemia a few months later. The drug has subsequently been approved in Canada, the U.K., the EU, Switzerland, the Kingdom of Saudi Arabia, the Kingdom of Bahrain, Qatar, the United Arab Emirates (UAE), and Kuwait. Crispr Therapeutics earns a 40% share of net profits from sales of Casgevy, with partner Vertex ( VRTX ) earning a 60% share (Vertex paid CRISPR ~$900m to change its share from 50% to 60% back in 2021). The revenue figure in Q1 2026 is $43m, which is in fact less than the figure in Q4 2025 of $54m - Casgevy earned a total of $116m of revenues in 2025 as a whole. On a...
The SaaS-pocalypse has caused quite a violent reset in the valuations of many software stocks. And while the disruptive wave of AI might not yet be done marking down prices across the SaaS scene, I do think that it makes sense to at least check out the prices on merchandise, which some folks might see ... The Same AI Wave Crushing SaaS Stocks May Be About to Rescue These 3 Names
The SaaS-pocalypse has caused quite a violent reset in the valuations of many software stocks. And while the disruptive wave of AI might not yet be done marking down prices across the SaaS scene, I do think that it makes sense to at least check out the prices on merchandise, which some folks might see ... The Same AI Wave Crushing SaaS Stocks May Be About to Rescue These 3 Names
US President Trump and Chinese President Xi will discuss China’s purchases of Iranian oil, Trade Representative Jamieson Greer said on "Bloomberg Surveillance." The two leaders are scheduled to meet in Beijing on May 14 and 15. (Source: Bloomberg)
US President Trump and Chinese President Xi will discuss China’s purchases of Iranian oil, Trade Representative Jamieson Greer said on "Bloomberg Surveillance." The two leaders are scheduled to meet in Beijing on May 14 and 15. (Source: Bloomberg)
Welcome back to Bloomberg’s Real Estate Monitor , a weekly breakdown of emerging trends, strategic challenges and blockbuster deals shaping the industry. Sign up now if you’re not already on the list. This week, we’ll update you on the feud between New York’s mayor and Citadel’s Ken Griffin . There’s also a big data center IPO coming up, a rare bid to sell an Aspen hotel and some upbeat news for h...
Welcome back to Bloomberg’s Real Estate Monitor , a weekly breakdown of emerging trends, strategic challenges and blockbuster deals shaping the industry. Sign up now if you’re not already on the list. This week, we’ll update you on the feud between New York’s mayor and Citadel’s Ken Griffin . There’s also a big data center IPO coming up, a rare bid to sell an Aspen hotel and some upbeat news for housing markets in the US , Canada and the UK . There’s more, too, so let’s get into it. — Christine Maurus Market Snapshot Vornado Realty Trust $30.26 +2.0% Equity Residential $66.25 +1.5% AvalonBay Communities Inc $185.25 +1.5% Blackstone Inc $122.72 -0.3% Market data as of 09:10 AM ET. Data is subject to provider delays. The big story The spat between financier Ken Griffin and New York City’s mayor has ticked up a notch or two. First, a quick catch-up: Last month, Mayor Zohran Mamdani singled out Griffin and his $238 million penthouse purchase in a now-viral video that touted a proposed tax on pricey pieds-a-terre and accused their buyers of not contributing enough to the city’s finances. That angered the billionaire Citadel chief, who threatened to back away from plans to build a new office skyscraper on Park Avenue. On Tuesday, Steven Roth, the CEO of Vornado Realty Trust, one of the partners on the office project, appealed to Mamdani to correct his “blunder” in making the social media post — one he called “irresponsible and dangerous” — and urged the mayor to be more welcoming to businesses. Roth, whose company also sold Griffin his penthouse at 220 Central Park South, said he still expects Griffin to remain committed to the $6 billion tower, which has been years in the making and is one of the most anticipated construction projects in Manhattan. Speaking on Vornado’s earnings conference call, Roth promised more clarity this summer. Griffin already has started to take control of the project, designed to bring the growing New York headcounts for Citadel and Citadel Secu...
Fan groups have called prices a ‘monumental betrayal’ Fifa collects 30% cut on resale markets Fifa president Gianni Infantino has defended World Cup ticket prices, insisting that football’s global governing body was obliged to take advantage of US laws that allow tickets to be resold for thousands of dollars above face value. Fifa has faced searing criticism over the cost of World Cup tickets, wit...
Fan groups have called prices a ‘monumental betrayal’ Fifa collects 30% cut on resale markets Fifa president Gianni Infantino has defended World Cup ticket prices, insisting that football’s global governing body was obliged to take advantage of US laws that allow tickets to be resold for thousands of dollars above face value. Fifa has faced searing criticism over the cost of World Cup tickets, with fan organization Football Supporters Europe (FSE) calling the pricing structure “extortionate” and a “monumental betrayal”. FSE filed a lawsuit with the European Commission in March targeting Fifa over “excessive ticket prices” for the tournament. Continue reading...
If you wanted to short China at lunch and be flat by the closing bell, Direxion Daily FTSE China Bear 3X Shares (NYSEARCA:YANG) is the tool. The fund aims to deliver three times the daily inverse return of the FTSE China 50 Index, the basket of large Chinese names that trade in Hong Kong. It ... How Investors Lost 89% Betting Against China — Even When Their Prediction Was Correct
If you wanted to short China at lunch and be flat by the closing bell, Direxion Daily FTSE China Bear 3X Shares (NYSEARCA:YANG) is the tool. The fund aims to deliver three times the daily inverse return of the FTSE China 50 Index, the basket of large Chinese names that trade in Hong Kong. It ... How Investors Lost 89% Betting Against China — Even When Their Prediction Was Correct
AMD to broaden and specialize EPYC CPUs, already working on Zen 7 architecture — increased customization to better address evolving AI and cloud needs Tom's Hardware
AMD to broaden and specialize EPYC CPUs, already working on Zen 7 architecture — increased customization to better address evolving AI and cloud needs Tom's Hardware
Joe Raedle/Getty Images News The Walt Disney Company ( DIS ) shares rose ~7% premarket after the entertainment giant reported better-than-expected quarterly results, driven by improved streaming profitability and stronger guest spending across its resorts and cruise business. Adjusted earnings rose to $1.57 per share in the fiscal second quarter, topping analyst expectations of $1.50 per share. Re...
Joe Raedle/Getty Images News The Walt Disney Company ( DIS ) shares rose ~7% premarket after the entertainment giant reported better-than-expected quarterly results, driven by improved streaming profitability and stronger guest spending across its resorts and cruise business. Adjusted earnings rose to $1.57 per share in the fiscal second quarter, topping analyst expectations of $1.50 per share. Revenue increased 7% year-over-year to $25.2B, also ahead of Wall Street estimates. Operating income across all three of its business divisions exceeded analyst expectations, while the company projected 12% earnings-per-share growth for the full fiscal year. Disney’s direct-to-consumer division, which includes the Disney+ streaming, delivered a double-digit operating profit margin for the first time, marking a major milestone in the company’s push to improve streaming profitability. The move could have implications beyond single-stock trading, with several exchange-traded funds exposed to Walt Disney Company ( DIS ) potentially benefiting from the rally, even as the stock remains down about 12% year-to-date. Among ETFs with notable Disney exposure 25 ETFs have Walt Disney Company within its Top 15 holdings as displayed below Motley Fool Value Factor ETF ( MFVL ): 4.93% Invesco S&P 500 Equal Weight Communication Services ETF ( RSPC ): 4.61% Communication Services Select Sector SPDR ETF ( XLC ): 4.56% First Trust S-Network Streaming and Gaming ETF ( BNGE ): 4.53% iShares Global Comm Services ETF ( IXP ): 4.44% Diamond Hill Large Cap Concentrated ETF ( DHLX ): 4.40% Fidelity MSCI Communication Services Index ETF ( FCOM ): 4.10% Vanguard Communication Services ETF ( VOX ): 4.04% Gabelli Opportunities In Live and Sports ETF ( GOLS ): 3.87% Invesco NASDAQ Internet ETF ( PNQI ): 3.68% Invesco Large Cap Value ETF ( PWV ): 3.10% Global X Millennial Consumer ETF ( MILN ): 2.99% iShares U.S. Consumer Discretionary ETF ( IYC ): 2.98% Global X PureCap MSCI Communication Services ETF ( GXP...
Chichester Festival theatre David Haig shines as writer and star of this dramatisation about the fraught friendship of two entertainment giants and their debate over what is real or simply illusion The admirable actor David Haig has a sprightly sideline as a writer of historical bio-dramas. My Boy Jack (1997), about Rudyard Kipling’s mourning for a son killed in the first world war, and Pressure (...
Chichester Festival theatre David Haig shines as writer and star of this dramatisation about the fraught friendship of two entertainment giants and their debate over what is real or simply illusion The admirable actor David Haig has a sprightly sideline as a writer of historical bio-dramas. My Boy Jack (1997), about Rudyard Kipling’s mourning for a son killed in the first world war, and Pressure (2014), concerning the Scottish meteorologist charged with finding Gen Eisenhower’s weather window for D-day, is followed by Magic, dramatising the fraught friendship of two giants of entertainment between the wars: Sir Arthur Conan Doyle and Harry Houdini. It overlaps with My Boy Jack in that, like the author of The Jungle Book, the creator of Sherlock Holmes is grieving for a war victim son. The hope of a reunion brings the writer to the spiritualist movement but creates tension with Houdini, the illusionist convinced that seances are as much a theatrical pretence as his own escapes from straitjackets and water tanks. Happy to have the Scot as a fan, the Hungarian-American is alarmed to discover that the writer believes him to be blessed with supernatural powers. Continue reading...
Sentinel Capital Partners on Wednesday said it has agreed to sell NSI Industries to Hubbell ( HUBB ) for $3.0 billion. NSI manufactures and supplies branded electrical power components, including fittings, connectors, and wire management products, serving industrial, infrastructure, and commercial markets. Sentinel acquired NSI in 2024 and later sold its HVAC division to Lennox International for a...
Sentinel Capital Partners on Wednesday said it has agreed to sell NSI Industries to Hubbell ( HUBB ) for $3.0 billion. NSI manufactures and supplies branded electrical power components, including fittings, connectors, and wire management products, serving industrial, infrastructure, and commercial markets. Sentinel acquired NSI in 2024 and later sold its HVAC division to Lennox International for about $550 million, repositioning the company as a pure-play electrical products business. The deal is subject to customary closing conditions, the company said. Source: Press Release More on Hubbell Hubbell: More M&A And Improved Organic Growth Hubbell strikes $3B deal for NSI Industries to boost electrical portfolio Hubbell targets $19.30-$19.85 adjusted EPS in 2026 as it raises sales growth outlook to 8%-11%
Here are Wednesday’s top Wall Street analyst research calls: Advanced Micro Devices, American Eagle Outfitters, GlobalFoundries, IAC, Merck, Palantir Technologies, Reddit, and more MSN
Here are Wednesday’s top Wall Street analyst research calls: Advanced Micro Devices, American Eagle Outfitters, GlobalFoundries, IAC, Merck, Palantir Technologies, Reddit, and more MSN
hapabapa Palantir Technologies ( PLTR ) was upgraded to Buy at Argus after it reported what the investment firm called a “stellar” first quarter. Shares fell fractionally in premarket trading on Wednesday. “Palantir had another stellar quarter in 1Q and is both accelerating revenue and expanding margin as its core U.S. government business is reaccelerating and as it continues expansion into the U....
hapabapa Palantir Technologies ( PLTR ) was upgraded to Buy at Argus after it reported what the investment firm called a “stellar” first quarter. Shares fell fractionally in premarket trading on Wednesday. “Palantir had another stellar quarter in 1Q and is both accelerating revenue and expanding margin as its core U.S. government business is reaccelerating and as it continues expansion into the U.S. commercial market,” analyst Joseph Bonner wrote in a note to clients. “This consistently strong fundamental performance comes against the backdrop of the PLTR shares being down more than 50% from their 2025 highs. Investors may have bunched Palantir in with others in the software technology industry that are believed to be vulnerable to disruption by GenAI models. Palantir's strong upward guidance revision in just the first quarter of 2026, as well as its actual results, provide a disconnect to the market's view—which we think can be exploited.” Bonner, who also raised his estimates on Palantir and put a $190 price target on the stock, said the expansion in the commercial market is likely to be a “key growth driver” over the following years. “As is the case with some others in the software industry, demand for the company's solutions is outstripping its ability to service new business,” Bonner added. “In our view, that is a high-class problem. Palantir is developing new, artificial intelligence-powered (AI-powered) applications and features to expand its business. While the PLTR shares have sold off in recent months, its valuation metrics remain exceptionally high. That said, we believe its fundamentals are also exceptionally strong.” More on Palantir Palantir: Hypergrowth Kicking In Palantir: Another Strong Earnings Report Palantir's Q1 Review: The Narrative Refuses To Turn, But It Should Army pushes tech giants, defense firms to 'hack’ weapons into AI-ready network Palantir stock drops despite strong results—These ETFs have the highest exposure
hapabapa Palantir Technologies ( PLTR ) was upgraded to Buy at Argus after it reported what the investment firm called a “stellar” first quarter. Shares fell fractionally in premarket trading on Wednesday. “Palantir had another stellar quarter in 1Q and is both accelerating revenue and expanding margin as its core U.S. government business is reaccelerating and as it continues expansion into the U....
hapabapa Palantir Technologies ( PLTR ) was upgraded to Buy at Argus after it reported what the investment firm called a “stellar” first quarter. Shares fell fractionally in premarket trading on Wednesday. “Palantir had another stellar quarter in 1Q and is both accelerating revenue and expanding margin as its core U.S. government business is reaccelerating and as it continues expansion into the U.S. commercial market,” analyst Joseph Bonner wrote in a note to clients. “This consistently strong fundamental performance comes against the backdrop of the PLTR shares being down more than 50% from their 2025 highs. Investors may have bunched Palantir in with others in the software technology industry that are believed to be vulnerable to disruption by GenAI models. Palantir's strong upward guidance revision in just the first quarter of 2026, as well as its actual results, provide a disconnect to the market's view—which we think can be exploited.” Bonner, who also raised his estimates on Palantir and put a $190 price target on the stock, said the expansion in the commercial market is likely to be a “key growth driver” over the following years. “As is the case with some others in the software industry, demand for the company's solutions is outstripping its ability to service new business,” Bonner added. “In our view, that is a high-class problem. Palantir is developing new, artificial intelligence-powered (AI-powered) applications and features to expand its business. While the PLTR shares have sold off in recent months, its valuation metrics remain exceptionally high. That said, we believe its fundamentals are also exceptionally strong.” More on Palantir Palantir: Hypergrowth Kicking In Palantir: Another Strong Earnings Report Palantir's Q1 Review: The Narrative Refuses To Turn, But It Should Army pushes tech giants, defense firms to 'hack’ weapons into AI-ready network Palantir stock drops despite strong results—These ETFs have the highest exposure